Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$403M |
| 2 |
Apple
AAPL
|
+$376M |
| 3 |
Tesla
TSLA
|
+$320M |
| 4 |
Amazon
AMZN
|
+$301M |
| 5 |
Johnson & Johnson
JNJ
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$469M |
| 2 |
Thomson Reuters
TRI
|
+$127M |
| 3 |
Chevron
CVX
|
+$93.7M |
| 4 |
SJR
Shaw Communications Inc.
SJR
|
+$67.2M |
| 5 |
iShares MSCI India ETF
INDA
|
+$52.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.75% |
| 2 | Healthcare | 13.35% |
| 3 | Financials | 11.75% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Orrstown Financial Services
ORRF
$838M
| $17.2K | ﹤0.01% |
899
| – | – |
|
3177
Fennec Pharmaceuticals
FENC
$391M
| $17.1K | ﹤0.01% |
+1,938
| New | +$16.1K |
|
|
SGMO
3178
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $17K | ﹤0.01% |
13,096
-17,917
| -58% | -$24.5K |
|
3179
PDS Biotechnology
PDSB
$42.2M
| $17K | ﹤0.01% |
+3,381
| New | +$22.1K |
|
3180
Zevra Therapeutics
ZVRA
$686M
| $17K | ﹤0.01% |
+3,325
| New | +$17.9K |
|
3181
PCB Bancorp
PCB
$391M
| $16.9K | ﹤0.01% |
1,152
| – | – |
|
|
KZR
3182
DELISTED
Kezar Life Sciences
KZR
| $16.7K | ﹤0.01% |
681
-4
| -0.6% | -$104 |
|
3183
Rallybio
RLYB
$87.6M
| $16.7K | ﹤0.01% |
368
+71
| +24% | +$3.48K |
|
3184
Altimmune
ALT
$589M
| $16.7K | ﹤0.01% |
4,722
+2,181
| +86% | +$9.79K |
|
|
OMGA
3185
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $16.6K | ﹤0.01% |
+2,971
| New | +$23.2K |
|
3186
Quantum-Si Incorporated
QSI
$177M
| $16.6K | ﹤0.01% |
9,294
| – | – |
|
|
PPTA
3187
Perpetua Resources
PPTA
$3.07B
| $16.5K | ﹤0.01% |
+4,510
| New | +$20.7K |
|
|
BCOV
3188
DELISTED
Brightcove, Inc.
BCOV
| $16.5K | ﹤0.01% |
4,122
-662
| -14% | -$2.68K |
|
3189
C&F Financial
CFFI
$284M
| $16.5K | ﹤0.01% |
+307
| New | +$16.3K |
|
|
GRTS
3190
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $16.5K | ﹤0.01% |
+8,443
| New | +$19.8K |
|
3191
First Bank
FRBA
$451M
| $16.4K | ﹤0.01% |
1,584
| – | – |
|
3192
Noodles & Co
NDLS
$107M
| $16.4K | ﹤0.01% |
607
| – | – |
|
3193
Capital Bancorp
CBNK
$611M
| $16.4K | ﹤0.01% |
906
+138
| +18% | +$2.36K |
|
3194
ALX Oncology
ALXO
$280M
| $16.4K | ﹤0.01% |
2,181
-1,083
| -33% | -$7.09K |
|
3195
Ponce Financial Group
PDLB
$483M
| $16.4K | ﹤0.01% |
+1,884
| New | +$14.7K |
|
3196
LanzaTech
LNZA
$71.1M
| $16.3K | ﹤0.01% |
+24
| New | +$9.48K |
|
3197
HireQuest
HQI
$178M
| $16.3K | ﹤0.01% |
+627
| New | +$14.7K |
|
3198
Tredegar Corp
TG
$304M
| $16.3K | ﹤0.01% |
2,438
-60,566
| -96% | -$480K |
|
|
PWOD
3199
DELISTED
Penns Woods Bancorp
PWOD
| $16.2K | ﹤0.01% |
+649
| New | +$15.7K |
|
|
VOXX
3200
DELISTED
VOXX International Corporation Class A
VOXX
| $16.2K | ﹤0.01% |
+1,297
| New | +$15.3K |
|
Similar funds
Legal & General Group's Q2 2023 Portfolio in Review
As of Q2 2023, Legal & General Group held 3,624 positions worth $307B, up 9.9% from $280B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Legal & General Group's Q2 2023 filing shows 248 new, 1,958 increased, 995 reduced and 215 closed positions. Its largest new stake was Eos Energy Enterprises: 8,222,102 shares worth $35.7M. The largest sale was Canadian Pacific Kansas City, an estimated $469M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2023 buy was Eos Energy Enterprises: 8,222,102 shares worth $35.7M.
- Legal & General Group added most to Microsoft in Q2 2023, an estimated $403M increase.
- Legal & General Group's biggest Q2 2023 reduction was Thomson Reuters, cutting an estimated $127M.
- Legal & General Group fully exited Canadian Pacific Kansas City in Q2 2023, selling an estimated $469M.
- Legal & General Group's ten largest holdings make up 26% of its $307B portfolio in Q2 2023.
- Legal & General Group opened 248 new positions and closed 215 in Q2 2023.
- Legal & General Group's portfolio value rose 9.9% quarter-over-quarter to $307B.
Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.